Natural Product Discovery Platform for Antimicrobial and Bioactive Compound Isolation from Ghanaian Medicinal Plants

Overview

This offering centers on the systematic discovery of bioactive natural products from plants, focusing on molecules with antimicrobial, antioxidant, and insect antifeedant properties. The research is grounded in the hypothesis that plants have evolved finely tuned chemical defenses against pests and pathogens, and that these same molecules can address human challenges in public health and food security. Prior work from the lead scientist's laboratory has already identified and structurally characterized natural products that target mitochondrial respiration pathways in pathogens, increase the susceptibility of hypoxic cells to chemotherapy, and induce programmed cell death. This track record demonstrates the versatility of plant-derived molecules and their potential across multiple therapeutic and agricultural applications.

Technical specifications

Core capabilities:

• Collection, drying, and milling of plant materials from multiple botanical families
• Extraction and isolation of crude and pure compounds from various plant parts
• Structure elucidation using spectroscopic methods and X-ray crystallographic techniques
• Antimicrobial activity testing against microbes relevant to public health and food security
• Insect antifeedant assays to evaluate pest-deterring properties
• Investigation of mechanisms of action, including mitochondrial respiration targeting and apoptosis induction

Key features:

• Proven ability to determine crystal structures of bioactive natural products
• Established bioassay workflows for antimicrobial and antifeedant screening
• Capacity to test molecules against multiple pathogen targets
• Track record of identifying compounds with both direct antimicrobial effects and adjuvant properties that enhance chemotherapy susceptibility

Technology readiness level

The platform is at an active research and validation stage. Several plant species have already been identified, with some materials harvested, dried, and stored for extraction and testing. Isolated compounds with characterized crystal structures and demonstrated bioactivities have been reported from the lead laboratory. The next phase of validation involves harvesting remaining identified plants, completing isolation and structure elucidation on at least two plant species, conducting antimicrobial and antifeedant assays, and publishing results within a 12-month timeframe. The offering is positioned for collaborative discovery partnerships rather than immediate commercial deployment.